Boothbay Fund Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Buy |
157,826
+78,745
| +100% | +$3.84M | 0.15% | 119 |
|
|
2025
Q1 | $1.7M | Buy |
79,081
+63,480
| +407% | +$1.37M | 0.04% | 369 |
|
|
2024
Q4 | $419K | Buy |
+15,601
| New | +$419K | 0.01% | 802 |
|
|
2019
Q3 | – | Sell |
-1,775
| Closed | -$60K | – | 687 |
|
|
2019
Q2 | $60K | Hold |
1,775
| – | – | 0.01% | 582 |
|
|
2019
Q1 | $94K | Hold |
1,775
| – | – | 0.01% | 563 |
|
|
2018
Q4 | $83K | Sell |
1,775
-385
| -18% | -$18K | 0.01% | 488 |
|
|
2018
Q3 | $190K | Hold |
2,160
| – | – | 0.02% | 537 |
|
|
2018
Q2 | $225K | Hold |
2,160
| – | – | 0.02% | 459 |
|
|
2018
Q1 | $173K | Sell |
2,160
-570
| -21% | -$45.7K | 0.02% | 507 |
|
|
2017
Q4 | $371K | Buy |
2,730
+1,315
| +93% | +$179K | 0.05% | 298 |
|
|
2017
Q3 | $229K | Sell |
1,415
-417
| -23% | -$67.5K | 0.04% | 387 |
|
|
2017
Q2 | $275K | Buy |
+1,832
| New | +$275K | 0.06% | 357 |
|